Navigation Links
NEBIDO in Medical News

Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options

...currently is pending U.S. Food and Drug Administration approval. Testosterone undecanoate was first approved in Europe in 2003 and is now marketed as nebido in more than 80 countries by Bayer Schering Pharma AG. ABOUT HYPOGONADISM Hypogonadism, also known as low testosterone, is a common yet la...

Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show

...thin the normal range over the 21-month study, and nebido was generally well tolerated. The long-term clini...rmal range throughout the 21-month study, and that nebido was generally well tolerated. nebido is currently under review at the U.S. Food and Dru...

Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals

... upon achievement of certain milestones related to nebido (R) (in development for hypogonadism) and the octr...ant interest in the downstream value creation from nebido and the octreotide implant. "Our employees, w...r. "Our sales force, Cranbury operations, and the nebido and Octreotide R&D teams are expected to play ...

Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals

...signed for easy, in-office physician insertion under local anesthesia. nebido is a novel, long-acting injectable testosterone depot being developed for t...to support regulatory review of the company's pending application to market nebido as the first long-acting testosterone preparation available in the United S...

Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results

...cipate being able to discuss our future plans with nebido in the coming months. "Our portfolio of marketed...gn our expense structure with the realities of the nebido delay," stated Dr. Cooper. "Our new operating plan...acement therapies. Indevus acquired U.S. rights to nebido from Bayer Schering Pharma AG, Germany in July 200...

Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status

...aneous post-marketing adverse event reports of the nebido 1000 mg (4ml) dose. In the Indevus U.S. clinical t...orts on patients having received the 1000 mg (4ml) nebido dose, FDA has asked for new data to more precisely... the FDA is taking regarding the safety profile of nebido given the large European experience. Rare coughing...

FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus

...n Drug User Fee Act (PDUFA) target action date for nebido is June 27, 2008. The NDA was submitted to the FDA...nce from over 260,000 injections of NEBIDO. About nebido NEBIDO(R) is a long-acting depot preparation of t... developed for the treatment of male hypogonadism. nebido is expected to be the first three-month testostero...
NEBIDO in Medical Technology

Indevus Reports Positive Data From Phase III NEBIDO Trial

Compound Achieves All Key Endpoints for Both Efficacy and Safety LEXINGTON, Mass., June 07, 2007 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. today announced final results from its Phase III pharmacokinetic trial for NEBIDO (testosterone undecanoate), a long- acting injectable testoster...

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

...pleased with the FDA's action and congratulate the nebido development team on reaching this milestone. We l...ook forward to receiving the FDA's decision on the nebido marketing application in September." About nebido ...

Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association

...riteria. Patients received injections of 750 mg of nebido at baseline, week 4, and week 14 of the study, and... developed for the treatment of male hypogonadism. nebido is expected to be the first long-acting testostero...sterone therapies. Indevus acquired U.S. rights to nebido from Bayer Schering Pharma AG, Germany in July 200...

Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)

... Company Files Additional Data to the nebido NDA PDUFA Date Expected to Remain Jun...al positive results from its Phase III program for nebido (testosterone undecanoate), a long-acting injectab...n Drug User Fee Act (PDUFA) target action date for nebido will remain June 27, 2008. The dosing regimen fo...

Indevus Announces Submission of New Drug Application

... Seeking Approval for nebido to Treat Male Hypogonadism LEXINGTON, Mass., Aug...ny) which has formed the basis for the approval of nebido in over 75 countries to date. The U.S. testostero...,000 injections of NEBIDO. "The submission of the nebido NDA is a very important milestone for the Company,...
NEBIDO in Biological Technology

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

...ghts During the past year, the Company achieved a number of important milestones, including: Clinical Development -- Results From nebido Phase III Trial Shows 94 Percent of Men Maintained Normal Testosterone Levels Throughout Treatment -- Results From Two-Year Study Confirmin...

Indevus and FDA Agree on Path Forward for NEBIDO(R)

...rge, simple post- marketing study of the safety of nebido in approximately 10,000 patients. "We are very p...uming approval, we will be in a position to launch nebido with our sales force in the fourth quarter of cale...osterone therapy and we expect the introduction of nebido to have a significant positive impact on the Compa...

Indevus Receives Approvable Letter from FDA for NEBIDO(R)

...any Announces Revised Operating Plan to Respond to nebido Delay LEXINGTON, Mass., June 30 /PRNewswire-Firs...mediately following the intramuscular injection of nebido 1000 mg, 4 cc injection volume, (versus the 750 mg...fainting. In the Company's U.S. clinical trials of nebido 750 mg (3 cc injection volume), the proposed dose ...
Other Tags
(Date:8/29/2014)... 29, 2014 Dr. Parsa Mohebi M.D. has ... hair loss achieve great results in hair transplantation. One ... Transplant , an FUE method that harvests facial hair for ... method lets patients whose hair loss classification is 5 and ... is a great alternative for those advanced hair loss patients ...
(Date:8/29/2014)... Highly regarded audiologist , Dr. Mary Ann Larkin has ... four reports are titled:, , Revealing the Truth ... , The Top 5 Things You Should Know Before ... in Children , Dr. Mary Anne Larkin choose to ... confusion and misinformation about each them. The reports are available ...
(Date:8/29/2014)... 2014 Pursuing its deepest desires to ... unveil a stunning new design that promises to redefine ... highly notable surrogacy platform has witnessed a 42 percent ... visitors a month, the FindSurrogateMother.com community is formed by ... common goal — the precious gift of life. , ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- If you have bunions, taking ... treatment later, an expert says. A bunion is a ... when bone or tissue moves out of place and extends ... can cause debilitating pain and may require surgery to correct, ... Medical Center in Freehold, N.J. To prevent bunions, avoid ...
(Date:8/29/2014)... August 29, 2014 - Despite US Preventive Services ... are many barriers, several of which may be ameliorated ... researchers at NYU Langone Medical Center published online August ... Medicine ( JGIM ). , David Levine, MD, ... Internal Medicine at NYU Langone, and colleagues found that ...
Breaking Medicine News(10 mins):Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Take Steps to Control Bunions 2Health News:Options for weight loss your primary care doctor might not know about 2
(Date:8/29/2014)... explored the type and number of connections in transcription ... on robustness in a study published in PLOS ... that the assortativity signature contributes to a network,s resilience ... varying the out-out assortativity of TFN models has a ... other three types of assortativity," said Dov A. Pechenick, ...
(Date:8/29/2014)... of marine phytoplankton, such as the prolific bloomer ... (thiamine), researchers have discovered. The finding contradicts the common ... eukaryotic microbes depend on scarce supplies of thiamine in ... way to think about the ocean," says CIFAR Senior ... ISME Journal paper with CIFAR fellows John ...
(Date:8/29/2014)... - The rise of the Tibetan plateau -- the ... is important for both its profound effect on climate ... published in GSA Bulletin , Katharine Huntington and ... thermometry -- using modern and fossil snail shells to ... southwestern Tibet. , Views range widely on the ...
Breaking Biology News(10 mins):Assortativity signatures of transcription factor networks contribute to robustness 2Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7
Other Contents